HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX

Abstract : During tumor invasion, tumor cells degrade the extracellular matrix. Basement membrane degradation is responsible for the production of peptides with anti-tumor properties. Type XIX collagen is associated with basement membranes in vascular, neuronal, mesenchymal and epithelial tissues. Previously, we demonstrated that the non-collagenous NC1, C-terminal, domain of collagen XIX [NC1(XIX)] inhibits the migration capacities of tumor cells and exerts a strong inhibition of tumor growth. Here, we demonstrate that plasmin, one of the most important enzyme involved in tumor invasion, was able to release a fragment of NC1(XIX), which retained the anti-tumor activity. Molecular modeling studies showed that NC1(XIX) and the antitumor fragment released by plasmin (F4) adopted locally the same type I β-turn conformation. This suggests that the anti-tumor effect is conformation-dependent. This study demonstrates that collagen XIX is a novel proteolytic substrate for plasmin. Such release may constitute a defense of the organism against tumor invasion.
Complete list of metadata

Contributor : Stéphanie Baud Connect in order to contact the contributor
Submitted on : Tuesday, January 25, 2022 - 10:00:41 AM
Last modification on : Friday, February 25, 2022 - 11:17:27 AM
Long-term archiving on: : Tuesday, April 26, 2022 - 6:52:48 PM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License




Jean-Baptiste Oudart, Sylvie Brassart-Pasco, Alexia Vautrin, Christèle Sellier, Carine Machado, et al.. Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX. Oncotarget, Impact journals, 2015, 6 (6), pp.3656-3668. ⟨10.18632/oncotarget.2849⟩. ⟨hal-03541824⟩



Record views


Files downloads